Webb, EJ 
ORCID: 0000-0001-7918-839X, King, N ORCID: 0000-0002-4215-2323, Howdon, D ORCID: 0000-0001-8052-2893, Carrol, ED ORCID: 0000-0001-8357-7726, Euden, J ORCID: 0000-0002-2844-6878, Howard, P ORCID: 0000-0002-5096-0240, Pallmann, P ORCID: 0000-0001-8274-9696, Llewelyn, MJ ORCID: 0000-0002-6811-1124, Thomas-Jones, E ORCID: 0000-0001-7716-2786, Shinkins, B ORCID: 0000-0001-5350-1018 et al (show 1 more authors)
(2024)
Evidence of quality of life for hospitalised patients with COVID-19: a scoping review
Health Technology Assessment Winchester England, 29 (52).
pp. 1-23.
ISSN 1366-5278, 2046-4924
Abstract
Background: Information on the quality of life of people hospitalised with COVID-19 is important, both in assessing the burden of disease and the cost-effectiveness of treatments. However, there were potential barriers to collecting such evidence. Objective: To review the existing evidence on quality of life for people hospitalised with COVID-19, with a focus on the amount of evidence available and methods used. Design: A scoping review with systematic searches. Results: A total of 35 papers were selected for data extraction. The most common study type was economic evaluation (N = 13), followed by cross-sectional (N = 10). All economic evaluations used published utility values for other conditions to represent COVID-19 inpatients' quality of life. The most popular quality-of-life survey measure was the Pittsburgh Sleep Quality Index (N = 8). There were 12 studies that used a mental health-related survey and 12 that used a sleep-related survey. Five studies used EQ-5D, but only one collected responses from people in the acute phase of COVID-19. Studies reported a negative impact on quality of life for people hospitalised with COVID-19, although many studies did not include a formal comparison group. Limitations: Although it used systematic searches, this was not a full systematic review. Conclusion: Quality-of-life data were collected from people hospitalised with COVID-19 from relatively early in the pandemic. However, there was a lack of consensus as to what survey measures to use, and few studies used generic health measures. Economic evaluations for COVID-19 treatments did not use utilities collected from people with COVID-19. In future health crises, researchers should be vigilant for opportunities to collect quality-of-life data from hospitalised patients but should try to co-ordinate as well as ensuring generic health measures are used more. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR132254.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised Patients (PEACH) Study Team |
| Divisions: | Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 10 Jun 2024 09:29 |
| Last Modified: | 28 Feb 2026 20:48 |
| DOI: | 10.3310/ATPR4281 |
| Open Access URL: | https://www.journalslibrary.nihr.ac.uk/hta/publish... |
| Related Websites: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3182093 |
| Disclaimer: | The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate. |
Altmetric
Altmetric